Aline Martin1, Valentin David2. 1. Division of Nephrology and Hypertension, Center for Translational Metabolism and Health and Feinberg Cardiovascular and Renal Research Institute, Northwestern University, 320 East Superior Street, Chicago, IL, 60611, USA. aline.martin@northwestern.edu. 2. Division of Nephrology and Hypertension, Center for Translational Metabolism and Health and Feinberg Cardiovascular and Renal Research Institute, Northwestern University, 320 East Superior Street, Chicago, IL, 60611, USA. valentin.david@northwestern.edu.
Abstract
PURPOSE OF REVIEW: The molecular mechanisms of the bone disease associated with chronic kidney disease (CKD), called renal osteodystrophy (ROD), are poorly understood. New transcriptomics technologies may provide clinically relevant insights into the pathogenesis of ROD. This review summarizes current progress and limitations in the study and treatment of ROD, and in transcriptomics analyses of skeletal tissues. RECENT FINDINGS: ROD is characterized by poor bone quality and strength leading to increased risk of fracture. Recent studies indicate permanent alterations in bone cell populations during ROD. Single-cell transcriptomics analyses, successful at identifying specialized cell subpopulations in bone, have not yet been performed in ROD. ROD is a widespread poorly understood bone disease with limited treatment options. Transcriptomics analyses of bone are needed to identify the bone cell subtypes and their role in the pathogenesis of ROD, and to develop adequate diagnosis and treatment strategies.
PURPOSE OF REVIEW: The molecular mechanisms of the bone disease associated with chronic kidney disease (CKD), called renal osteodystrophy (ROD), are poorly understood. New transcriptomics technologies may provide clinically relevant insights into the pathogenesis of ROD. This review summarizes current progress and limitations in the study and treatment of ROD, and in transcriptomics analyses of skeletal tissues. RECENT FINDINGS:ROD is characterized by poor bone quality and strength leading to increased risk of fracture. Recent studies indicate permanent alterations in bone cell populations during ROD. Single-cell transcriptomics analyses, successful at identifying specialized cell subpopulations in bone, have not yet been performed in ROD. ROD is a widespread poorly understood bone disease with limited treatment options. Transcriptomics analyses of bone are needed to identify the bone cell subtypes and their role in the pathogenesis of ROD, and to develop adequate diagnosis and treatment strategies.
Entities:
Keywords:
Bone and mineral metabolism; Bulk RNA sequencing; Chronic kidney disease; Renal osteodystrophy; Single-cell RNA sequencing; Transcriptomics
Authors: Ashish K Sharma; Nigel D Toussaint; Rosemary Masterson; Stephen G Holt; Chamith S Rajapakse; Peter R Ebeling; Sindhu T Mohanty; Paul Baldock; Grahame J Elder Journal: Am J Nephrol Date: 2018-05-23 Impact factor: 3.754
Authors: Christopher L Newman; Neal X Chen; Eric Smith; Mark Smith; Drew Brown; Sharon M Moe; Matthew R Allen Journal: Bone Date: 2015-04-17 Impact factor: 4.398
Authors: A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen Journal: Kidney Int Date: 2000-07 Impact factor: 10.612
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Yifu Fang; Charles Ginsberg; Michael Seifert; Olga Agapova; Toshifumi Sugatani; Thomas C Register; Barry I Freedman; Marie-Claude Monier-Faugere; Hartmut Malluche; Keith A Hruska Journal: J Am Soc Nephrol Date: 2014-02-27 Impact factor: 10.121
Authors: Renata C Pereira; Isidro B Salusky; Paul Roschger; Klaus Klaushofer; Ora Yadin; Earl G Freymiller; Richard Bowen; Anne M Delany; Nadja Fratzl-Zelman; Katherine Wesseling-Perry Journal: Kidney Int Date: 2018-11 Impact factor: 10.612
Authors: Florence Lima; Hanna Mawad; Amr A El-Husseini; Daniel L Davenport; Hartmut H Malluche Journal: Clin Nephrol Date: 2019-04 Impact factor: 0.975
Authors: Guaraciaba O Ferrari; Juliana C Ferreira; Raquel T Cavallari; Katia R Neves; Luciene M dos Reis; Wagner V Dominguez; Elizabeth C Oliveira; Fabiana G Graciolli; Jutta Passlick-Deetjen; Vanda Jorgetti; Rosa M A Moysés Journal: BMC Nephrol Date: 2014-05-03 Impact factor: 2.388